Search by Drug Name or NDC
NDC 00143-9270-01 Floxuridine 100 mg/mL Details
Floxuridine 100 mg/mL
Floxuridine is a INTRA-ARTERIAL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is FLOXURIDINE.
MedlinePlus Drug Summary
Floxuridine is used to treat cancer of gastrointestinal (GI) tract (cancer of the stomach or intestines) that has spread to the liver. Floxuridine is in a class of medications called antimetabolites. It works by slowing or stopping the growth of cancer cells in your body.
Related Packages: 00143-9270-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Floxuridine
Product Information
NDC | 00143-9270 |
---|---|
Product ID | 0143-9270_0ee8505b-6680-410d-94bf-d55558a8c0e8 |
Associated GPIs | 21300020002105 |
GCN Sequence Number | 008803 |
GCN Sequence Number Description | floxuridine VIAL 500 MG INJECTION |
HIC3 | V1B |
HIC3 Description | ANTINEOPLASTIC - ANTIMETABOLITES |
GCN | 38531 |
HICL Sequence Number | 003909 |
HICL Sequence Number Description | FLOXURIDINE |
Brand/Generic | Generic |
Proprietary Name | Floxuridine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Floxuridine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route | INTRA-ARTERIAL |
Active Ingredient Strength | 100 |
Active Ingredient Units | mg/mL |
Substance Name | FLOXURIDINE |
Labeler Name | Hikma Pharmaceuticals USA Inc. |
Pharmaceutical Class | Antimetabolite [EPC], Deoxyuridine [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA075387 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00143-9270-01 (00143927001)
NDC Package Code | 0143-9270-01 |
---|---|
Billing NDC | 00143927001 |
Package | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9270-01) / 5 mL in 1 VIAL |
Marketing Start Date | 2018-02-15 |
NDC Exclude Flag | N |
Pricing Information | N/A |